Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ziprasidone vs Placebo in the Prevention of Psychosis Among Symptomatic Adolescents and Young Adults at Prodromal Risk

NCT00635700 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00635700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00635700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ziprasidone vs Placebo in the Prevention of Psychosis Among Symptomatic Adolescents and Young Adults at Prodromal Risk
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
November 30, 2012
Enrollment
51 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis prodrome